nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—SHBG—metabolic syndrome X	0.687	0.769	CbGaD
Norethindrone—ALB—metabolic syndrome X	0.206	0.231	CbGaD
Norethindrone—Abdominal bloating—Metformin—metabolic syndrome X	0.00174	0.137	CcSEcCtD
Norethindrone—Gastrointestinal symptom NOS—Metformin—metabolic syndrome X	0.00141	0.111	CcSEcCtD
Norethindrone—PGR—artery—metabolic syndrome X	0.000983	0.173	CbGeAlD
Norethindrone—Desogestrel—SHBG—metabolic syndrome X	0.000968	0.116	CrCbGaD
Norethindrone—Danazol—CCL2—metabolic syndrome X	0.000887	0.106	CrCbGaD
Norethindrone—Ethinyl Estradiol—NR1I2—metabolic syndrome X	0.000813	0.0976	CrCbGaD
Norethindrone—Etonogestrel—SHBG—metabolic syndrome X	0.000784	0.094	CrCbGaD
Norethindrone—PGR—blood vessel—metabolic syndrome X	0.000766	0.135	CbGeAlD
Norethindrone—Renal impairment—Metformin—metabolic syndrome X	0.000632	0.0499	CcSEcCtD
Norethindrone—Pain in extremity—Metformin—metabolic syndrome X	0.000601	0.0475	CcSEcCtD
Norethindrone—Migraine—Metformin—metabolic syndrome X	0.000592	0.0467	CcSEcCtD
Norethindrone—Levonorgestrel—SHBG—metabolic syndrome X	0.000554	0.0665	CrCbGaD
Norethindrone—Breast disorder—Metformin—metabolic syndrome X	0.000543	0.0429	CcSEcCtD
Norethindrone—Fluoxymesterone—SHBG—metabolic syndrome X	0.000528	0.0634	CrCbGaD
Norethindrone—Abdominal distension—Metformin—metabolic syndrome X	0.000523	0.0413	CcSEcCtD
Norethindrone—Danazol—SHBG—metabolic syndrome X	0.000505	0.0606	CrCbGaD
Norethindrone—Cortisone acetate—NR3C1—metabolic syndrome X	0.00048	0.0576	CrCbGaD
Norethindrone—Ethinyl Estradiol—SHBG—metabolic syndrome X	0.000467	0.0561	CrCbGaD
Norethindrone—Drowsiness—Metformin—metabolic syndrome X	0.000463	0.0366	CcSEcCtD
Norethindrone—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000438	0.0346	CcSEcCtD
Norethindrone—Methyltestosterone—SHBG—metabolic syndrome X	0.000427	0.0512	CrCbGaD
Norethindrone—Hepatitis—Metformin—metabolic syndrome X	0.000416	0.0328	CcSEcCtD
Norethindrone—Connective tissue disorder—Metformin—metabolic syndrome X	0.000409	0.0323	CcSEcCtD
Norethindrone—SHBG—cardiovascular system—metabolic syndrome X	0.000379	0.0669	CbGeAlD
Norethindrone—Immune system disorder—Metformin—metabolic syndrome X	0.000376	0.0297	CcSEcCtD
Norethindrone—Flatulence—Metformin—metabolic syndrome X	0.000357	0.0282	CcSEcCtD
Norethindrone—CYP3A7—liver—metabolic syndrome X	0.000349	0.0616	CbGeAlD
Norethindrone—PGR—cardiovascular system—metabolic syndrome X	0.000342	0.0603	CbGeAlD
Norethindrone—SHBG—adipose tissue—metabolic syndrome X	0.000334	0.059	CbGeAlD
Norethindrone—Hydrocortisone—SHBG—metabolic syndrome X	0.000321	0.0386	CrCbGaD
Norethindrone—Fluoxymesterone—NR3C1—metabolic syndrome X	0.000314	0.0377	CrCbGaD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000306	0.0242	CcSEcCtD
Norethindrone—PGR—adipose tissue—metabolic syndrome X	0.000301	0.0531	CbGeAlD
Norethindrone—CYP3A7-CYP3A51P—liver—metabolic syndrome X	0.000297	0.0524	CbGeAlD
Norethindrone—Oedema—Metformin—metabolic syndrome X	0.000295	0.0233	CcSEcCtD
Norethindrone—Skin disorder—Metformin—metabolic syndrome X	0.000287	0.0227	CcSEcCtD
Norethindrone—Somnolence—Metformin—metabolic syndrome X	0.000263	0.0207	CcSEcCtD
Norethindrone—Progesterone—SHBG—metabolic syndrome X	0.000262	0.0314	CrCbGaD
Norethindrone—Dyspepsia—Metformin—metabolic syndrome X	0.00026	0.0205	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000255	0.0201	CcSEcCtD
Norethindrone—Fatigue—Metformin—metabolic syndrome X	0.000255	0.0201	CcSEcCtD
Norethindrone—Testosterone—SHBG—metabolic syndrome X	0.000247	0.0297	CrCbGaD
Norethindrone—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000242	0.0191	CcSEcCtD
Norethindrone—ABCB1—blood vessel—metabolic syndrome X	0.000237	0.0417	CbGeAlD
Norethindrone—Urticaria—Metformin—metabolic syndrome X	0.000235	0.0185	CcSEcCtD
Norethindrone—SHBG—liver—metabolic syndrome X	0.000234	0.0414	CbGeAlD
Norethindrone—Abdominal pain—Metformin—metabolic syndrome X	0.000234	0.0184	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—metabolic syndrome X	0.000229	0.0275	CrCbGaD
Norethindrone—Asthenia—Metformin—metabolic syndrome X	0.000212	0.0167	CcSEcCtD
Norethindrone—Pruritus—Metformin—metabolic syndrome X	0.000209	0.0165	CcSEcCtD
Norethindrone—Dizziness—Metformin—metabolic syndrome X	0.000195	0.0154	CcSEcCtD
Norethindrone—CYP3A5—kidney—metabolic syndrome X	0.000194	0.0343	CbGeAlD
Norethindrone—ALB—liver—metabolic syndrome X	0.000194	0.0342	CbGeAlD
Norethindrone—Hydrocortisone—NR3C1—metabolic syndrome X	0.000191	0.0229	CrCbGaD
Norethindrone—Vomiting—Metformin—metabolic syndrome X	0.000188	0.0148	CcSEcCtD
Norethindrone—Rash—Metformin—metabolic syndrome X	0.000186	0.0147	CcSEcCtD
Norethindrone—Dermatitis—Metformin—metabolic syndrome X	0.000186	0.0147	CcSEcCtD
Norethindrone—Headache—Metformin—metabolic syndrome X	0.000185	0.0146	CcSEcCtD
Norethindrone—Nausea—Metformin—metabolic syndrome X	0.000176	0.0139	CcSEcCtD
Norethindrone—CYP3A5—adipose tissue—metabolic syndrome X	0.000175	0.0309	CbGeAlD
Norethindrone—CYP2C19—liver—metabolic syndrome X	0.000156	0.0275	CbGeAlD
Norethindrone—Progesterone—NR3C1—metabolic syndrome X	0.000156	0.0187	CrCbGaD
Norethindrone—CYP3A4—kidney—metabolic syndrome X	0.000146	0.0257	CbGeAlD
Norethindrone—Methyltestosterone—ALB—metabolic syndrome X	0.000128	0.0154	CrCbGaD
Norethindrone—CYP3A5—liver—metabolic syndrome X	0.000123	0.0217	CbGeAlD
Norethindrone—ABCB1—cardiovascular system—metabolic syndrome X	0.000106	0.0186	CbGeAlD
Norethindrone—ABCB1—kidney—metabolic syndrome X	0.000103	0.0182	CbGeAlD
Norethindrone—ABCB1—adipose tissue—metabolic syndrome X	9.3e-05	0.0164	CbGeAlD
Norethindrone—CYP3A4—liver—metabolic syndrome X	9.22e-05	0.0163	CbGeAlD
Norethindrone—Testosterone—ALB—metabolic syndrome X	7.44e-05	0.00893	CrCbGaD
Norethindrone—ABCB1—liver—metabolic syndrome X	6.52e-05	0.0115	CbGeAlD
Norethindrone—PGR—Signaling Pathways—LPL—metabolic syndrome X	3.09e-05	0.000386	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	3.08e-05	0.000384	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—CD36—metabolic syndrome X	3.07e-05	0.000383	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PLA2G6—metabolic syndrome X	3.03e-05	0.000379	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—FABP4—metabolic syndrome X	3.01e-05	0.000375	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—HMGCR—metabolic syndrome X	3e-05	0.000375	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GOT2—metabolic syndrome X	3e-05	0.000375	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOA5—metabolic syndrome X	3e-05	0.000375	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.99e-05	0.000374	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.94e-05	0.000367	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—FABP4—metabolic syndrome X	2.93e-05	0.000366	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.93e-05	0.000365	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HSD11B1—metabolic syndrome X	2.85e-05	0.000356	CbGpPWpGaD
Norethindrone—ALB—Metabolism—G6PD—metabolic syndrome X	2.83e-05	0.000353	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—TRIB3—metabolic syndrome X	2.79e-05	0.000349	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.79e-05	0.000349	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	2.78e-05	0.000347	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.76e-05	0.000345	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HDAC3—metabolic syndrome X	2.76e-05	0.000345	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LPA—metabolic syndrome X	2.7e-05	0.000337	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GCKR—metabolic syndrome X	2.7e-05	0.000337	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.69e-05	0.000336	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ABCA1—metabolic syndrome X	2.68e-05	0.000334	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—SLC2A4—metabolic syndrome X	2.68e-05	0.000334	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—APOA1—metabolic syndrome X	2.67e-05	0.000334	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AGT—metabolic syndrome X	2.64e-05	0.00033	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.64e-05	0.000329	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLA2G6—metabolic syndrome X	2.61e-05	0.000326	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—TGFB1—metabolic syndrome X	2.6e-05	0.000325	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.6e-05	0.000324	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GGT1—metabolic syndrome X	2.59e-05	0.000324	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—GOT1—metabolic syndrome X	2.59e-05	0.000324	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—LEP—metabolic syndrome X	2.59e-05	0.000323	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APOE—metabolic syndrome X	2.59e-05	0.000323	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOA5—metabolic syndrome X	2.59e-05	0.000323	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2.56e-05	0.00032	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	2.56e-05	0.00032	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—APOA1—metabolic syndrome X	2.56e-05	0.000319	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—G6PD—metabolic syndrome X	2.54e-05	0.000317	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FMO3—metabolic syndrome X	2.54e-05	0.000317	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.51e-05	0.000314	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.51e-05	0.000313	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NAMPT—metabolic syndrome X	2.51e-05	0.000313	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GCK—metabolic syndrome X	2.49e-05	0.000311	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—LIPC—metabolic syndrome X	2.49e-05	0.000311	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—G6PD—metabolic syndrome X	2.48e-05	0.00031	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	2.48e-05	0.00031	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOC3—metabolic syndrome X	2.47e-05	0.000309	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.47e-05	0.000308	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.46e-05	0.000308	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.43e-05	0.000304	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LPA—metabolic syndrome X	2.42e-05	0.000303	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GCKR—metabolic syndrome X	2.42e-05	0.000303	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HDAC3—metabolic syndrome X	2.42e-05	0.000302	CbGpPWpGaD
Norethindrone—ALB—Metabolism—TRIB3—metabolic syndrome X	2.41e-05	0.0003	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CETP—metabolic syndrome X	2.4e-05	0.0003	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	2.39e-05	0.000298	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LPA—metabolic syndrome X	2.36e-05	0.000295	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GCKR—metabolic syndrome X	2.36e-05	0.000295	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	2.35e-05	0.000293	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.33e-05	0.000291	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOA5—metabolic syndrome X	2.32e-05	0.00029	CbGpPWpGaD
Norethindrone—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	2.31e-05	0.000289	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IRS1—metabolic syndrome X	2.31e-05	0.000288	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SCARB1—metabolic syndrome X	2.3e-05	0.000287	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	2.29e-05	0.000286	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOA5—metabolic syndrome X	2.27e-05	0.000283	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	2.26e-05	0.000282	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	2.26e-05	0.000282	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.26e-05	0.000282	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—IGF1—metabolic syndrome X	2.24e-05	0.000279	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SREBF1—metabolic syndrome X	2.23e-05	0.000279	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.21e-05	0.000276	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—INS—metabolic syndrome X	2.21e-05	0.000276	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOB—metabolic syndrome X	2.2e-05	0.000275	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.19e-05	0.000273	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—CCL2—metabolic syndrome X	2.17e-05	0.000272	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—HMGCR—metabolic syndrome X	2.17e-05	0.000271	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GOT2—metabolic syndrome X	2.17e-05	0.000271	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.16e-05	0.00027	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	2.16e-05	0.00027	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NAMPT—metabolic syndrome X	2.16e-05	0.000269	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.14e-05	0.000268	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LIPC—metabolic syndrome X	2.14e-05	0.000268	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GCK—metabolic syndrome X	2.14e-05	0.000268	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PLA2G4A—metabolic syndrome X	2.14e-05	0.000267	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IGF1—metabolic syndrome X	2.14e-05	0.000267	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOC3—metabolic syndrome X	2.13e-05	0.000266	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	2.13e-05	0.000265	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—SERPINE1—metabolic syndrome X	2.12e-05	0.000265	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—TRIB3—metabolic syndrome X	2.11e-05	0.000263	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—LPL—metabolic syndrome X	2.1e-05	0.000262	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CETP—metabolic syndrome X	2.07e-05	0.000258	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—SERPINE1—metabolic syndrome X	2.03e-05	0.000254	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	2.03e-05	0.000253	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—NOS3—metabolic syndrome X	2.03e-05	0.000253	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—CD36—metabolic syndrome X	2e-05	0.000249	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SCARB1—metabolic syndrome X	1.98e-05	0.000247	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—NOS3—metabolic syndrome X	1.94e-05	0.000242	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	1.94e-05	0.000242	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ABCA1—metabolic syndrome X	1.94e-05	0.000242	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—SLC2A4—metabolic syndrome X	1.94e-05	0.000242	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.93e-05	0.00024	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LIPC—metabolic syndrome X	1.92e-05	0.00024	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GCK—metabolic syndrome X	1.92e-05	0.00024	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SREBF1—metabolic syndrome X	1.92e-05	0.00024	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOC3—metabolic syndrome X	1.91e-05	0.000239	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NAMPT—metabolic syndrome X	1.89e-05	0.000236	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GCK—metabolic syndrome X	1.88e-05	0.000235	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LIPC—metabolic syndrome X	1.88e-05	0.000235	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GOT1—metabolic syndrome X	1.88e-05	0.000234	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—GGT1—metabolic syndrome X	1.88e-05	0.000234	CbGpPWpGaD
Norethindrone—ALB—Metabolism—HMGCR—metabolic syndrome X	1.87e-05	0.000234	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT2—metabolic syndrome X	1.87e-05	0.000234	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOC3—metabolic syndrome X	1.87e-05	0.000233	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CETP—metabolic syndrome X	1.86e-05	0.000232	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARA—metabolic syndrome X	1.86e-05	0.000232	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CETP—metabolic syndrome X	1.81e-05	0.000226	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.81e-05	0.000226	CbGpPWpGaD
Norethindrone—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	1.81e-05	0.000226	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AGT—metabolic syndrome X	1.8e-05	0.000225	CbGpPWpGaD
Norethindrone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	1.78e-05	0.000222	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	1.78e-05	0.000222	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOE—metabolic syndrome X	1.76e-05	0.00022	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—APOA1—metabolic syndrome X	1.74e-05	0.000217	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SCARB1—metabolic syndrome X	1.74e-05	0.000217	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.73e-05	0.000216	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	1.73e-05	0.000216	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	1.71e-05	0.000214	CbGpPWpGaD
Norethindrone—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.69e-05	0.000211	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SREBF1—metabolic syndrome X	1.68e-05	0.00021	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	1.68e-05	0.00021	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT2—metabolic syndrome X	1.68e-05	0.00021	CbGpPWpGaD
Norethindrone—ALB—Metabolism—ABCA1—metabolic syndrome X	1.67e-05	0.000208	CbGpPWpGaD
Norethindrone—ALB—Metabolism—SLC2A4—metabolic syndrome X	1.67e-05	0.000208	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—HMGCR—metabolic syndrome X	1.64e-05	0.000205	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT2—metabolic syndrome X	1.64e-05	0.000205	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GGT1—metabolic syndrome X	1.61e-05	0.000202	CbGpPWpGaD
Norethindrone—ALB—Metabolism—GOT1—metabolic syndrome X	1.61e-05	0.000202	CbGpPWpGaD
Norethindrone—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.61e-05	0.000201	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOB—metabolic syndrome X	1.59e-05	0.000199	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PLA2G4A—metabolic syndrome X	1.55e-05	0.000193	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PPARG—metabolic syndrome X	1.53e-05	0.000192	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.53e-05	0.000191	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—LPL—metabolic syndrome X	1.52e-05	0.00019	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.51e-05	0.000189	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—INS—metabolic syndrome X	1.5e-05	0.000188	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	1.5e-05	0.000187	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	1.5e-05	0.000187	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.49e-05	0.000186	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.46e-05	0.000182	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.46e-05	0.000182	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.46e-05	0.000182	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.46e-05	0.000182	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GGT1—metabolic syndrome X	1.45e-05	0.000181	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—GOT1—metabolic syndrome X	1.45e-05	0.000181	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—CD36—metabolic syndrome X	1.44e-05	0.00018	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.41e-05	0.000177	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.41e-05	0.000177	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.41e-05	0.000176	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.4e-05	0.000174	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—ALB—metabolic syndrome X	1.38e-05	0.000172	CbGpPWpGaD
Norethindrone—PGR—Gene Expression—AKT1—metabolic syndrome X	1.37e-05	0.000171	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOB—metabolic syndrome X	1.37e-05	0.000171	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARA—metabolic syndrome X	1.34e-05	0.000168	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—TGFB1—metabolic syndrome X	1.34e-05	0.000167	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PLA2G4A—metabolic syndrome X	1.33e-05	0.000166	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—NOS3—metabolic syndrome X	1.32e-05	0.000165	CbGpPWpGaD
Norethindrone—ALB—Metabolism—LPL—metabolic syndrome X	1.31e-05	0.000163	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AGT—metabolic syndrome X	1.3e-05	0.000162	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.3e-05	0.000162	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—TGFB1—metabolic syndrome X	1.28e-05	0.00016	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOE—metabolic syndrome X	1.27e-05	0.000159	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—APOA1—metabolic syndrome X	1.26e-05	0.000157	CbGpPWpGaD
Norethindrone—ALB—Metabolism—CD36—metabolic syndrome X	1.24e-05	0.000155	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOB—metabolic syndrome X	1.23e-05	0.000154	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—PTGS2—metabolic syndrome X	1.21e-05	0.000151	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOB—metabolic syndrome X	1.2e-05	0.00015	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	1.2e-05	0.000149	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—LPL—metabolic syndrome X	1.17e-05	0.000147	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.17e-05	0.000146	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.16e-05	0.000145	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.16e-05	0.000145	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.16e-05	0.000145	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARA—metabolic syndrome X	1.16e-05	0.000144	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.15e-05	0.000144	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—LPL—metabolic syndrome X	1.15e-05	0.000143	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AGT—metabolic syndrome X	1.12e-05	0.00014	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.12e-05	0.000139	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—CD36—metabolic syndrome X	1.12e-05	0.000139	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PPARG—metabolic syndrome X	1.11e-05	0.000139	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOE—metabolic syndrome X	1.1e-05	0.000137	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—CD36—metabolic syndrome X	1.09e-05	0.000136	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—INS—metabolic syndrome X	1.09e-05	0.000136	CbGpPWpGaD
Norethindrone—ALB—Metabolism—APOA1—metabolic syndrome X	1.08e-05	0.000135	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.07e-05	0.000134	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.04e-05	0.00013	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARA—metabolic syndrome X	1.04e-05	0.00013	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.01e-05	0.000126	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.01e-05	0.000126	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.01e-05	0.000126	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AGT—metabolic syndrome X	1e-05	0.000125	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—ALB—metabolic syndrome X	9.97e-06	0.000125	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOE—metabolic syndrome X	9.84e-06	0.000123	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AGT—metabolic syndrome X	9.81e-06	0.000122	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—APOA1—metabolic syndrome X	9.73e-06	0.000122	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—IL6—metabolic syndrome X	9.66e-06	0.000121	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOE—metabolic syndrome X	9.61e-06	0.00012	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PPARG—metabolic syndrome X	9.55e-06	0.000119	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—NOS3—metabolic syndrome X	9.54e-06	0.000119	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—APOA1—metabolic syndrome X	9.5e-06	0.000119	CbGpPWpGaD
Norethindrone—ALB—Metabolism—INS—metabolic syndrome X	9.37e-06	0.000117	CbGpPWpGaD
Norethindrone—ALB—Hemostasis—AKT1—metabolic syndrome X	9.32e-06	0.000116	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	9e-06	0.000112	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	9e-06	0.000112	CbGpPWpGaD
Norethindrone—PGR—Signaling Pathways—AKT1—metabolic syndrome X	8.91e-06	0.000111	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	8.73e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.72e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.72e-06	0.000109	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PPARG—metabolic syndrome X	8.58e-06	0.000107	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—INS—metabolic syndrome X	8.41e-06	0.000105	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PPARG—metabolic syndrome X	8.37e-06	0.000105	CbGpPWpGaD
Norethindrone—ALB—Metabolism—NOS3—metabolic syndrome X	8.22e-06	0.000103	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—INS—metabolic syndrome X	8.21e-06	0.000103	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—ALB—metabolic syndrome X	7.71e-06	9.63e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—ALB—metabolic syndrome X	7.53e-06	9.4e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—PTGS2—metabolic syndrome X	7.51e-06	9.38e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.4e-06	9.24e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—NOS3—metabolic syndrome X	7.38e-06	9.21e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—NOS3—metabolic syndrome X	7.2e-06	8.99e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.2e-06	8.99e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.06e-06	8.82e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	6.75e-06	8.42e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.71e-06	8.38e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—PTGS2—metabolic syndrome X	6.58e-06	8.22e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.24e-06	7.79e-05	CbGpPWpGaD
Norethindrone—CYP3A7—Metabolism—AKT1—metabolic syndrome X	6.07e-06	7.58e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.04e-06	7.55e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.92e-06	7.39e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.85e-06	7.31e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.16e-06	6.44e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—INS—metabolic syndrome X	5.06e-06	6.32e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.64e-06	5.79e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.44e-06	5.54e-05	CbGpPWpGaD
Norethindrone—CYP3A5—Metabolism—AKT1—metabolic syndrome X	4.39e-06	5.48e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.06e-06	5.07e-05	CbGpPWpGaD
Norethindrone—ALB—Metabolism—AKT1—metabolic syndrome X	3.78e-06	4.72e-05	CbGpPWpGaD
Norethindrone—CYP2C19—Metabolism—AKT1—metabolic syndrome X	3.39e-06	4.23e-05	CbGpPWpGaD
Norethindrone—ABCB1—Metabolism—AKT1—metabolic syndrome X	3.31e-06	4.13e-05	CbGpPWpGaD
Norethindrone—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.04e-06	2.55e-05	CbGpPWpGaD
